![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication January 8, 2008.
Revised May 9, 2008.
Accepted for publication May 9, 2008.
Previous studies suggested that histamine (HA) acts as an autocrine growth factor. We have explored the modulation of cell proliferation by HA using McA-RH7777 hepatoma cells. A high L-histidine decarboxylase (HDC) expression and HA synthesis was found in McA-RH7777 cells. Whereas extracellular HA reached sub-micromolar concentrations, intracellular levels were very low, indicating that HA was secreted by the cells. McA-RH7777 cells also express H3 receptor (H3R) transcripts and proteins. RT-PCR analysis detected only transcripts for the long isoform. Immunocytochemistry performed with a selective H3R antibody showed that most cells were immunoreactive. H3R binding sites (Bmax ~ 30 fmol/mg protein) were identified when [125I]iodoproxyfan binding was displaced by the agonist imetit. A high affinity binding also occurred at cytochrome P450 enzymes. This binding was not inhibited by HA, H3R agonists or by a non imidazole H3R antagonist, but was displaced by imidazole H3R antagonists or by ketoconazole, a imidazole-containing cytochrome inhibitor. HA inhibited proliferation of McA-RH7777 hepatoma cells. The absence of uptake system, its much higher potency at H3Rs, and its low intracellular levels, suggested that HA interacted with H3Rs rather than cytochromes. In agreement, both imidazole H3R antagonists, a non imidazole H3R antagonist, and the HDC inhibitor
-FMH, increased cell proliferation (up to ~ 60 %), revealing a H3R-mediated inhibition by endogenous HA. Moreover, exogenous HA inhibited the increase induced by
-FMH or H3R antagonists with a nanomolar potency. In conclusion, our findings show that HA regulates proliferation of McA-RH7777 hepatoma cells by interacting with autoinhibitory H3Rs.
Key words:
Autoinhibition, Cell proliferation, Cytochromes, H3 receptor, Hepatoma, Histamine